|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/10 | |
| A61K 31/454 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2240466 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09700579.7 |
| Europos patento paraiškos padavimo data | 2009-01-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-10-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2009/000041 |
| Data | 2009-01-08 |
| (87) | Numeris | WO 2009/087381 |
| Data | 2009-07-16 |
| (30) | Numeris | Data | Šalis |
| 10333 | 2008-01-08 | US |
| (72) |
FOLEY, Jennifer, R., US
WILSON, Robert, Darrin, GB
|
| (73) |
Merck Sharp & Dohme Limited,
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU,
GB
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US |
| (54) | PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3- YL]PHENYL} -2H-INDAZOLE-7-CARBOXAMIDE |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3- YL]PHENYL} -2H-INDAZOLE-7-CARBOXAMIDE |